ASH 2023 | Phase I trial of copanlisib + nivolumab in patients with Richter’s transformation or transformed FL
In this video, Geoffrey Shouse, DO, PhD, City of Hope, Duarte, CA, gives an overview of a Phase I trial evaluating the safety and efficacy of copanlisib in combination with nivolumab in patients with transformed follicular lymphoma (FL) and Richter’s transformation (RT; NCT03884998). A small subset of patients with RT responded to this combination, and in patients with transformed FL, a promising response rate was observed, although the duration of response (DoR) was shorter. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Speakers Bureau: Beigene, Inc., Kite Pharmaceuticals
Consultancy: Kite Pharmaceuticals
